Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Genua

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|February 10, 2012
Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform AAlaide Morcavallo, Marco Genua, Angela Palummo, et al.
Journal of Cellular Physiology|April 1, 2014
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expressionLaura Sciacca, Maria Francesca Cassarino, Marco Genua, et al.
Plos One|August 4, 2012
Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cellsMarco Genua, Shi-Qiong Xu, Simone Buraschi, et al.
Inflammatory Bowel Diseases|August 19, 2016
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage PolarizationMarco Genua, Vincenzo Ingangi, Philippe Fonteyne, et al.
The Journal of Biological Chemistry|August 16, 2011
Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signalingRenato V Iozzo, Simone Buraschi, Marco Genua, et al.
The Journal of Clinical Investigation|August 9, 2014
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel diseaseSilvia D'Alessio, Carmen Correale, Carlotta Tacconi, et al.
Oncotarget|April 4, 2015
A novel role for drebrin in regulating progranulin bioactivity in bladder cancerShi-Qiong Xu, Simone Buraschi, Alaide Morcavallo, et al.
Gut|May 23, 2014
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammationMarco Genua, Silvia D'Alessio, Javier Cibella, et al.
The American Journal of Pathology|April 17, 2010
The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillinDavid Metalli, Francesca Lovat, Farida Tripodi, et al.
Nature Communications|July 26, 2018
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigensGiulia Escobar, Luigi Barbarossa, Giulia Barbiera, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|February 10, 2012
Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform AAlaide Morcavallo, Marco Genua, Angela Palummo, et al.
Journal of Cellular Physiology|April 1, 2014
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expressionLaura Sciacca, Maria Francesca Cassarino, Marco Genua, et al.
Plos One|August 4, 2012
Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cellsMarco Genua, Shi-Qiong Xu, Simone Buraschi, et al.
Inflammatory Bowel Diseases|August 19, 2016
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage PolarizationMarco Genua, Vincenzo Ingangi, Philippe Fonteyne, et al.
The Journal of Biological Chemistry|August 16, 2011
Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signalingRenato V Iozzo, Simone Buraschi, Marco Genua, et al.
The Journal of Clinical Investigation|August 9, 2014
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel diseaseSilvia D'Alessio, Carmen Correale, Carlotta Tacconi, et al.
Oncotarget|April 4, 2015
A novel role for drebrin in regulating progranulin bioactivity in bladder cancerShi-Qiong Xu, Simone Buraschi, Alaide Morcavallo, et al.
Gut|May 23, 2014
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammationMarco Genua, Silvia D'Alessio, Javier Cibella, et al.
The American Journal of Pathology|April 17, 2010
The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillinDavid Metalli, Francesca Lovat, Farida Tripodi, et al.
Nature Communications|July 26, 2018
Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigensGiulia Escobar, Luigi Barbarossa, Giulia Barbiera, et al.
Pageof 4